US Patent 7553953 Chimeric, human and humanized anti-CSAp monoclonal antibodies
Patent 7553953 was granted and assigned to IMMUNOMEDICS, INC. on June, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+227 characters)
Article
Patent abstract
The present invention provides humanized, chimeric and human anti-CSAp antibodies and anti-CSAp antibody fusion proteins that are useful for the treatment and diagnosis of various cancers, including colon cancer.
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07553953 Chimeric, human and humanized anti-CSAp monoclonal antibodies US Patent 7553953 Chimeric, human and humanized anti-CSAp monoclonal antibodies
Infobox
Patent Number
0755395300
Patent Number
755395300
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075539530
Date of Patent
June 30, 2009
0Patent Application Number
120420630
Date Filed
March 4, 2008
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075539530
Date of Patent
June 30, 2009
0Patent Application Number
120420630
Date Filed
March 4, 2008
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07553953 Chimeric, human and humanized anti-CSAp monoclonal antibodies
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07553953
Date of patent
June 30, 2009
Patent application number
12042063
Date Filed
March 4, 2008
Patent primary examiner
Find more entities like US Patent 7553953 Chimeric, human and humanized anti-CSAp monoclonal antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
